COHANCE LIFESCIENCES
Back to Balance Sheet
|
COHANCE LIFESCIENCES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹488 Cr | ₹1,136 Cr | ₹852 Cr | ₹918 Cr | ₹345 Cr |
What is the latest Net Current Assets ratio of COHANCE LIFESCIENCES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹488 Cr |
| Mar2024 | ₹1,136 Cr |
| Mar2023 | ₹852 Cr |
| Mar2022 | ₹918 Cr |
| Mar2021 | ₹345 Cr |
How is Net Current Assets of COHANCE LIFESCIENCES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹488 Cr | -57.03 | |
| Mar2024 | ₹1,136 Cr | 33.27 | |
| Mar2023 | ₹852 Cr | -7.12 | |
| Mar2022 | ₹918 Cr | 165.95 | |
| Mar2021 | ₹345 Cr | - | |
Compare Net Current Assets of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹16,937.7 Cr | -2% | 2.4% | -55.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | -2% |
2.4% |
-55.9% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses